Clinical Trial Update: The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effectiveness and safety of sequential intravesical mitomycin-C and gemcitabine for bladder cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Bladder Cancer | Phase 2 | Status: RECRUITING